Bottom line
JNGLX vs LBWAX: the short answer
JNGLX (Janus Henderson Global Life Sciences Fund) and LBWAX (BrandywineGLOBAL - Diversified US Large Cap Value Fund) are quite different portfolios: only about 15% of their top holdings (by weight) are shared.
But LBWAX is far broader, holding 223 positions to 108 for JNGLX, so beyond the top names it adds exposure JNGLX doesn't have.
JNGLX is cheaper at 0.81% vs 1.16% — a difference of $35 a year per $10,000 invested.
LBWAX has a front-end sales load of up to 5.5%; the other does not.
Updated Nov 19, 2026
JNGLX vs LBWAX side by side
| JNGLX | LBWAX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Janus Henderson | Franklin Templeton |
| Category | Global Stock | Global Stock |
| Expense ratio | 0.81% | 1.16% |
| Annual cost per $10k | $81 | $116 |
| 10-yr cost on $10k (prospectus) | $1,002 | $1,962 |
| Max front load | — | 5.5% |
| 12b-1 fee | — | 0.25% |
| 1-yr return | — | +10.5% |
| 5-yr return (annualized) | — | +12.1% |
| 10-yr return (annualized) | — | +10.4% |
| Best quarter | +21.0% | +16.0% |
| Worst quarter | −13.6% | −27.4% |
| Net assets (fund) | $5.8B | $110.9M |
| Number of holdings | 108 | 223 |
| Portfolio turnover | 3% | 57% |
| Returns as of | — | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | JNGLX | LBWAX | Difference |
|---|---|---|---|
| 2025 | +24.8% | +16.9% | +7.9% |
| 2024 | +3.6% | +18.3% | −14.7% |
| 2023 | +7.5% | +7.1% | +0.4% |
| 2022 | −2.7% | −1.9% | −0.8% |
| 2021 | +6.8% | +29.3% | −22.5% |
| 2020 | +25.6% | −1.7% | +27.3% |
| 2019 | +29.2% | +25.3% | +3.9% |
| 2018 | +4.3% | −9.3% | +13.6% |
| 2017 | +22.6% | +19.7% | +2.9% |
| 2016 | −12.3% | +13.8% | −26.2% |
Source: Fund prospectus bar charts
Holdings overlap
4 of JNGLX's top 25 holdings also appear in LBWAX's top 25.
| Holding | JNGLX | LBWAX |
|---|---|---|
| Johnson & Johnson | 7.09% | 3.78% |
| Merck & Co., Inc. | 1.87% | 1.44% |
| Amgen, Inc. | 1.64% | 1.40% |
| Gilead Sciences, Inc. | 1.39% | 1.07% |
Source: SEC Form N-PORT
JNGLX top 10
- Eli Lilly & Co. — 9.41%
- Johnson & Johnson — 7.09%
- AbbVie, Inc. — 4.67%
- UnitedHealth Group, Inc. — 4.54%
- AstraZeneca plc — 3.93%
- Revolution Medicines, Inc. — 3.02%
- Argenx SE — 2.63%
- Novartis AG — 2.56%
- Thermo Fisher Scientific, Inc. — 2.33%
- Praxis Precision Medicines, Inc. — 2.19%
LBWAX top 10
- Jpmorgan Chase & Co — 4.34%
- Johnson & Johnson — 3.78%
- Exxonmobil Holdings Corp — 3.27%
- Apple Inc — 2.64%
- Morgan Stanley — 2.49%
- Goldman Sachs Group Inc — 2.34%
- Microsoft Corp — 2.30%
- Qualcomm Inc — 2.18%
- Bank Of America Corp — 2.04%
- Walt Disney Company (the) — 1.90%
FAQ
What is the difference between JNGLX and LBWAX?
Which is cheaper, JNGLX or LBWAX?
Should I own both JNGLX and LBWAX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.